InnovAge Appoints Jennifer Browne as President & COO to Drive Operational Improvement
INNV has more than doubled off its 52-week low of $3.13.
Summary
InnovAge appointed Jennifer Browne as President and COO, a key hire with a strong background in value-based care and operational improvement, signaling a strategic focus on strengthening company performance.
Key Events · Executive and Board Changes · INNV
-
New President & COO Appointed
Jennifer Browne has been appointed President and Chief Operating Officer, effective June 8, 2026.
-
Extensive Healthcare Experience
Ms. Browne previously served as COO at Strive Health and SVP of Value & Population Health at Optum, bringing deep experience in value-based care, operational leadership, and compliance.
-
Strategic Focus on Performance
Her role will focus on driving consistent execution, enhancing participant experience, and advancing performance across operational and compliance metrics, directly addressing areas of recent company challenge.
-
Comprehensive Compensation Package
Compensation includes an annual base salary of $500,000, a $200,000 sign-on bonus, a target annual cash bonus of 75% of base salary, and annual restricted stock unit grants with a target value of $500,000, plus 1,260,000 Class B Units in TCO Group Holdings with a hurdle amount of $7.14.
Analysis · INNV · Industrial Applications And Services
InnovAge has appointed Jennifer Browne as its new President and Chief Operating Officer. This is a significant C-suite hire, particularly given the company's recent report of increased net losses due to litigation expenses. Ms. Browne's background in value-based kidney care, operational leadership, and compliance is directly aligned with InnovAge's stated focus on disciplined execution, regulatory excellence, and sustainable growth. Her appointment signals a strategic move to strengthen core operations and enhance performance.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, INNV was trading at $7.56 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1B. The 52-week trading range was $3.13 to $10.69. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.